Oral celecoxib (COX-2 inhibitor) vs placebo
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Oral celecoxib (COX-2 inhibitor) showed no clear difference in pain intensity (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review
- Pharmacological interventions for pain in patients with temporomandibular disorders 2010 · Cochrane All outcomes6 weeksMD 0.03 [-0.40, 0.45]1 study · 68 participantsGRADE not reported